Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-02-22 @ 6:42 AM
Study NCT ID:
NCT02187705
Status:
COMPLETED
Last Update Posted:
2014-07-11
First Post:
2014-07-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Micardis® in Patients With Essential Hypertension
Sponsor:
Boehringer Ingelheim
Organization:
Study Overview
Official Title:
Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals
Status:
COMPLETED
Status Verified Date:
2014-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this observational study was to supplement the data on efficacy, safety, and tolerability of telmisartan under daily conditions in hospitals
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: